Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Pharmacy negotiators urge DHSC to allow pharmacies to trade stock without wholesale licence after Brexit

Community Pharmacy Scotland and the Pharmaceutical Services Negotiating Committee have called for restrictions on pharmacy-to-pharmacy wholesale dealing without a licence to be relaxed to allow pharmacists to manage medicines shortages after Brexit.

Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee

Source: Jeff Gilbert

Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee, wrote to the House of Commons Health and Social Care Select Committee calling for pharmacists to be allowed to trade stocks to reduce the impact of medicines shortages after Brexit

Pharmacists should be allowed to exchange stocks of medicines to mitigate local medicines shortages after Brexit, pharmacy leaders have said.

In an update on Brexit contingency planning, Community Pharmacy Scotland called for the Department of Health and Social Care to “relax the restrictions on pharmacy-to-pharmacy wholesale dealing without [a] wholesaler dealers licence” to help manage drugs shortages.

The statement added that relaxing the rules “would allow pharmacies to trade stock between them at a local level, helping to allow medicines to reach those patients who most need them without regulatory barriers”.

In a letter sent to the House of Commons Health and Social Care Select Committee on 7 December 2018, the Pharmaceutical Services Negotiating Committee (PSNC) called for the same intervention, adding that processes must be in place after Brexit “to help community pharmacies and other healthcare providers to work together to manage any shortages that do occur”.

This follows an urgent government consultation launched on 7 December 2018, which proposed giving pharmacists the ability to switch a patient’s medication to a suitable alternative when the prescribed drug is in short supply, without consulting the patient’s GP.

The letter to the select committee, signed by Simon Dukes, chief executive of the PSNC, also expressed concern over the financial impact of medicines shortages on pharmacies more generally.

It said: “The PSNC is concerned about the impact that shortages on a significant scale could have on pharmacies’ cashflow and workload at a time when many pharmacies are already under significant pressure following funding cuts to the sector.”

To mitigate the financial risk, the PSNC suggests working with the government to ensure “community pharmacies have quicker and clearer reimbursement and stock availability information”, as well as reimbursement “of any additional costs incurred to help them to cover their costs and continue to offer the full range of patient services”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205889

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.